"Fair Allocation of GLP-1 and Dual GLP-1–GIP Receptor Agonists" is now out in NEJM (w/Zeke Emanuel, Johan Dellgren, Matt McCoy). We propose a #bioethics framework to guide gov'ts, professional societies, & docs in allocation choices about drugs like semaglutide (Ozempic/Wegovy) when demand > supply

North Carolina & other health systems are being unethical when they categorically refuse to cover GLP-1 receptor agonists (e.g. Ozempic, Mounjaro) for obesity. So I & Zeke Emanuel argue in our Wall Street Journal op-ed. I highlight some of our points below in replies #bioethics

…of a paper that determines my judgement of the paper. But the assumptions and starting points of the argument should be reasonable to anyone. In that sense I can offer a fair review of a paper even if the conclusion is something that I deeply disagree with.

No, I think value judgements are inevitable, even in the sciences ppl make (epistemic) value judgements all the time - though often implicitly. On top of that It seems impossible to do (and review in) ethics in a morally neutral way. But it should not be my own moral perspective on the conclusion…

Revised draft of “Antiracist Medicine in Colorblind Courts,” forthcoming in the Michigan Law Review papers.ssrn.com/sol3/papers.... Added material on new §1981, §1557, & Equal Protection litigation against health & other programs that consider individuals’ race New TX & UT laws are also discussed

Thanks to the University of Denver's #RadioEd podcast for featuring my research on healthcare affordability! I analyze health affordability in depth in my "Defining Health Affordability," published (open access) in the Iowa Law Review: ilr.law.uiowa.edu/volume-109-i... #healthlaw #bioethics

I was today years old when I learned that Philippa Foot (of trolley problem/virtue ethics fame) was Grover Cleveland’s granddaughter

Just listened to interesting Philosophy Bites on transformative experience. Do people really think decisions about whether to become a parent are arational, as opposed to just characterized by imperfect info & value change? Imperfect info, likelihood of change in values ≠ arationality.

The Biounethical podcast with Sophie Gibert & @leahpierson.bsky.social has been great listening material for my New Year’s resolution to walk more. Just finished episode w/Danielle Allen on #bioethics & public participation & now in the middle of one with Jeff Sebo on the circle of moral concern

I appreciated Robert Califf & Peter Marks at FDA writing on undervaccination and dangers to population immunity But surprised to see not one mention of politics or partisanship as a cause of undervaccination. Curious if they can't say it, or if they don't think it's a cause.

TIL: some believe that if research participants respond regularly & at a high rate to text-message surveys because of: - a motivation to improve the quality of the research output - a desire to be thought well of by the researchers this might be . . . ethically concerning coercion

As a fun post-tenure thing, I'm going to try to post favorite health law/policy/bioethics articles on Fridays. Not always ones I perfectly agree with, but ones I've gotten something from. Rules: - Before 2018 - Ideally, not already super famous - Not hard-paywalled

Curious (or worried) about how #SCOTUS affirmative action decisions may hamper antiracist efforts in medicine? Happy to share that “Antiracist Medicine in Colorblind Courts” is forthcoming in the Michigan Law Review. Comments welcome! Draft: https://tinyurl.com/AntiracistMedicine Abstract ⬇

[crossposting] I am pleased to share that I’m now (as of Aug. 1) Associate Professor with Tenure at the University of Denver Sturm College of Law. . I’m grateful to the external and internal mentors who supported me through this process, to all my collaborators, and to the outside reviewers.